StARD6 Inhibitors

StARD6 inhibitors encompass chemicals that modulate lipid-related pathways or proteins. While not directly inhibiting StARD6, these compounds can exert effects on pathways and processes that StARD6 is anticipated to be involved in. Filipin III, a polyene antibiotic, can disrupt lipid rafts, thereby influencing proteins associated with lipid transport and cholesterol binding. U18666A, another chemical, alters cholesterol trafficking, which can have implications for proteins like StARD6 engaged in lipid transport.

Sphingomyelinases, pivotal in lipid metabolism, can be inhibited by compounds such as GW4869. Given the relationship of StARD6 with steroidogenic proteins, steroid compounds like progesterone can also impact its activity or associated pathways. The extraction of cholesterol from membranes by MβCD might alter the function of StARD6, suggesting a modulatory role. A significant portion of the compounds, including Lovastatin, Simvastatin, Atorvastatin, Rosuvastatin, Pitavastatin, and Pravastatin, belong to the statin class. These compounds inhibit HMG-CoA reductase, a key enzyme in cholesterol synthesis. By altering cholesterol synthesis and levels, these compounds can indirectly influence lipid transport proteins and their associated activities. Finally, AY 9944 offers a unique mechanism by inhibiting desmosterol reductase, another enzyme key to cholesterol biosynthesis.